- Source:
- Treating and Preventing Adolescent Mental Health Disorders: What We Know and What We Don't Know. A Research Agenda for Improving the Mental Health of Our Youth
Abuse child neuroendocrine changes,
[link] physical, suicidal behavior and,
[link]
Access to mental health services to
substance abuse treatment for
step-down services,
[link] system change considerations,
[link]
Adolescence.
See also[link] mental health problems during.
See[link];
specific disorders weight loss interventions during,
[link]
Adolescent Transitions Program,
[link]
Affective disorders.
See[link]
African Americans access to mental health services,
[link]
After-school programs, for positive youth development,
[link],
[link]
Aggressive behavior.
See also[link]
Alaskan Natives, suicide rate,
[link]
Alcohol use and abuse and
alcohol dependence as adult,
[link] in “gateway” hypothesis,
[link] and
use of emergency department,
[link] zero-tolerance policies,
[link]
Alcohol use disorders (AUDs)
Allostasis, brain reward center, in substance use disorders,
[link]
Alprazolam, for panic disorder,
[link]
American Academy of Pediatrics, eating disorders treatment guidelines,
[link]
American Indians, suicide rate,
[link]
American Psychiatric Association, eating disorders treatment guidelines,
[link]
American Psychological Association, standards for evidence-based mental health services,
[link]
Amygdala extended, in drug addiction,
[link]
Annenberg Public Policy Center primary care physician survey,
[link] school mental health professionals survey,
[link]
Annie E. Casey Foundation Blue Sky Project,
[link]
Anorexia nervosa.
See also[link] prevention programs,
[link] in high-risk populations and settings,
[link] psychosocial therapy,
[link] randomized controlled trials,
[link]
Anticonvulsants, in schizophrenia,
[link]
Antidepressants.
See also specific drugs heterocyclic, for major depressive disorder,
[link] for
major depressive disorder in children and adolescents,
[link] public health advisory on,
[link] selective serotonin and noradrenaline reuptake inhibitor, for major depressive disorder,
[link] selective serotonin reuptake inhibitor.
See[link] tricyclic for
major depressive disorder
Antipsychotics.
See also specific drugs for
major depressive disorder,
[link]
Anxiety disorders,
[link] brain developmental changes,
[link] disability requirement,
[link] electroencephalography,
[link] emotional processing theory,
[link] etiology and maintenance theories,
[link] fear structures cognitive-behavioral therapy and,
[link] emotional processing theory and,
[link] generalized in children and adolescents,
[link] treatment,
[link]t,
[link]t
in children and adolescents,
[link] management of partial response and nonresponse to,
[link] obsessive-compulsive disorder as.
See[link] pharmacotherapy with cognitive-behavioral therapy,
[link] post-traumatic stress disorder as.
See[link] treatment,
[link] management of partial response and nonresponse to,
[link]
Anxiety Disorders Interview Schedule for Children,
[link]
Arnarson and Craighead program for prevention of depression,
[link]
Asian Americans, suicide rate,
[link]
Association studies, in schizophrenia,
[link]
Asthma, depression and,
[link]
Attachment as
outcome of positive youth development,
[link] security in, depression and,
[link]
(p. 794)
Attachment-based family therapy, for major depressive disorder,
[link]
Attention deficit, in children of schizophrenic parents,
[link],
[link]
Attention-deficit/hyperactivity disorder, comorbidity substance use disorder,
[link]
Attentional threat bias, in anxiety disorders,
[link]
Attributional style, pessimistic and
vulnerability to depression,
[link]
Attributions, stigma and,
[link]
Australia, depression prevention programs,
[link]
Automobile accidents, alcohol-related,
[link]
Autonomic nervous system abnormalities, in anxiety disorders,
[link],
[link]
Basal ganglia, and motor dysfunction in schizophrenia,
[link]
Beardslee program for prevention of depression,
[link]
Behavior genetic theory of substance abuse,
[link]
Behavioral competence, as outcome of positive youth development,
[link]
Behavioral inhibition selective prevention intervention for,
[link]
Behavioral managed care,
[link]
Behavioral therapy.
See also[link] for
major depressive disorder,
[link] for
separation anxiety disorder,
[link] for
substance use disorders,
[link]
Belief in future, as outcome of positive youth development,
[link]
Benzodiazepines for
separation anxiety disorder,
[link]
Bibliotherapy, for subsyndromal depression,
[link]
Big Brothers and Big Sisters,
[link]t
Biological factors.
See also[link] in positive youth development,
[link]
Bipolar disorder hypomania in (type II),
[link] hypothalamic-pituitary-adrenal axis hyperactivity,
[link] not otherwise specified,
[link] prepubertal, versus adolescent-onset,
[link] treatment research agenda,
[link]
Blood alcohol level (BAL),
[link]
Body fat, fear of, as criterion for anorexia nervosa,
[link]
Bonding, as outcome of positive youth development,
[link]
Bone mineral density, in anorexia nervosa,
[link]
Borderline personality disorder, plus suicidal behavior, dialectical behavioral therapy for,
[link]
Brain.
See also[link] abnormalities in children of schizophrenic parents,
[link] executive inhibitory circuitry defects, in substance use disorders,
[link] imaging in substance use disorders,
[link]
Brief dynamic therapy, for major depressive disorder,
[link]
Brief interventions, for substance use,
[link]
Brief strategic family therapy, for substance use disorders,
[link]
Bulimia nervosa.
See also[link] prevention programs,
[link] in high-risk populations and settings,
[link]
Bupropion for
ADHD plus substance use disorder,
[link] for
major depressive disorder,
[link]
Calcium supplementation, in anorexia nervosa,
[link]
California, reform initiatives on delivery of evidence-based practices,
[link]
Carbamazepine for
post-traumatic stress disorder,
[link]
Caring School Community,
[link]t
CASASTART (Striving Together to Achieve Rewarding Tomorrows),
[link]
Case identification, in mental health disorders,
[link],
[link]
Catatonic features, depression with,
[link]
Catchment approach, for prevention of substance abuse,
[link]
Catechol-O-methyl transferase (COMT), as schizophrenia susceptibility gene,
[link],
[link]
Center for Mental Health Services System of Care,
[link]
Center for Prevention Research,
[link]
Central intake unit, for substance abuse treatment,
[link]
(p. 796)
Change consensual theory of, in positive youth development field,
[link] organizational readiness,
[link]
Chemical dependency.
See[link]
Child abuse neuroendocrine changes,
[link]
Child and Adolescent Service System Program (CASSP),
[link]
Child and Adolescent Trauma Screen (CATS),
[link]
Child Behavior Checklist (CBCL),
[link]
Child PTSD Symptom Scale (CPSS),
[link]
Child welfare system, substance abuse identification,
[link]
Children.
See also[link] bipolar disorder in, versus adolescent-onset,
[link] generalized anxiety disorder in,
[link] major depressive disorder in obsessive-compulsive disorder in,
[link] post-traumatic stress disorder in,
[link] schizophrenia in, event-related potentials in,
[link],
[link]t
social anxiety disorder in,
[link] weight loss interventions for,
[link]
CHRNA7, as schizophrenia susceptibility gene,
[link]
Clarke program for prevention of depression,
[link]
Classical conditioning in substance use disorders,
[link]
Climate, organizational,
[link]
Clinic-community intervention model for treatment development,
[link]
Clonidine, for post-traumatic stress disorder,
[link]
Clozapine for
psychotic disorder and suicidal behavior,
[link] for
suicide attempters,
[link]
Cognitive-behavioral analysis system of psychotherapy, for major depressive disorder,
[link]
Cognitive-behavioral therapy for
anxiety disorders developmental considerations,
[link] education and skill-building,
[link] for
major depressive disorder symptomatic community samples,
[link] for
substance use disorders,
[link] for
subsyndromal depression,
[link]
(p. 797)
Cognitive competence, as outcome of positive youth development,
[link]
Cognitive diathesis-stress model, of depression,
[link]
Cognitive remediation therapy, for schizophrenia,
[link]
Combined drug and psychosocial treatments
Commitment, organizational,
[link]
Community depression prevention interventions,
[link] mental health service reform initiatives,
[link] therapeutic, for substance use disorders,
[link]
Community assessment centers, for substance abuse treatment,
[link]
Community factors, in anxiety disorders,
[link]
Community-system approach, for substance abuse prevention,
[link]
Comorbidity issues in evidence-based mental health services,
[link]
Competencies, as outcome of positive youth development,
[link],
[link]
Compliance therapy, for schizophrenia,
[link]
Comprehensive Community Mental Health Services for Children and Families (CMHSC),
[link]
Conditioning, classical in substance use disorders,
[link]
Conduct disorder, comorbidity
Confidentiality in suicide screening programs,
[link]
Consent for services, minor,
[link]
Contact effects, in reducing stigma of mental illness,
[link],
[link]
Context factors, in implementation and dissemination of evidence-based mental health services,
[link]
Contingency management incentive systems, for substance use disorders,
[link]
Control, perceived, in anxiety disorders,
[link]
Coping and Support Training (CAST),
[link]
The Coping Cat Workbook, [link]
Coping skills strategies, in anxiety disorders,
[link]
Coping with Depression–Adolescent version,
[link] “coping with stress” adaptation of,
[link]
Corticotropin-releasing factor, in stress response,
[link]
Counseling genetic, in schizophrenia,
[link]
Counselors Care (C-CARE),
[link]
Credentialing process, substance abuse treatment,
[link]
Criminal behavior, and anxiety disorders,
[link]
Cultural factors.
See also[link] in access to mental health services,
[link] in alcohol use disorders,
[link] in positive youth development,
[link]
Culture, organizational,
[link]
Dade County, Florida, suicide prevention program,
[link]
“Dealing with it” approach,
[link]
Dependence disorders, chemical.
See[link]
Depression with atypical features,
[link] with catatonic features,
[link] cognitive diathesis-stress model,
[link] help-Seeking behavior for, perceived effectiveness,
[link],
[link]t
hypothalamic-pituitary-adrenal axis hyperactivity,
[link] interpersonal vulnerability,
[link] major cognitive vulnerability to,
[link] interpersonal vulnerability,
[link] personality/temperament and,
[link] pharmacotherapy.
See also[link] prevention programs,
[link] future directions and recommendations,
[link] psychosocial therapy in children and adolescents,
[link] relationship to schizophrenia,
[link] treatment research agenda,
[link] with melancholic features,
[link] self-propagating nature,
[link] specific vulnerability hypothesis,
[link] subsyndromal cognitive-behavioral therapy for,
[link] as
risk factor for major depression,
[link]
Development youth problem-centered approach,
[link]
Developmental assets, in positive youth development,
[link]
Developmental group therapy, for suicidal youth,
[link]t,
[link]
Diagnostic and Statistical Manual for Primary Care (DSM-PC), eating disorders criteria,
[link]
Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV) criteria
(p. 799)
alcohol abuse and dependence,
[link]
Dialectical behavioral therapy
Diathesis-stress model of depression,
[link]
Dietary restraint, definition,
[link]
Dieting.
See also[link] professionally administered effects on eating behavior,
[link] effects on psychological status,
[link]
Disorder, harmful dysfunction account of,
[link]
Disorganization, in schizophrenia,
[link]
Disruptive behavior disorders, plus depression,
[link],
[link]
Disulfiram, for alcohol use disorders,
[link]
Divaloproex with lithium, for bipolar disorder,
[link]
Dorsal lateral prefrontal cortex, developmental changes,
[link]
Dot Probe Attention Allocation Task,
[link]
Drug Abuse Resistance Education (DARE),
[link]
Drug Abuse Warning Network (DAWN),
[link]
DSM-IV diagnostic criteria.
See[link]
Duloxetine, for major depressive disorder,
[link]
Dysbindin, as schizophrenia susceptibility gene,
[link]
Dysthymic disorder plus major depressive disorder,
[link]
Ecological approach to youth development,
[link]
Effectiveness, organizational requirements for,
[link]
Electrolyte abnormalities, in eating disorders,
[link]t
Electrophysiology, in schizophrenia,
[link]
Emotion(s) brain circuitry for, developmental shifts,
[link] expressed, reduction, family therapy for,
[link]
Emotional competence, as outcome of positive youth development,
[link]
Engagement, pursuit of, in positive psychology,
[link]
Environmental factors in substance use disorders,
[link]
Escitalopram, for major depressive disorder,
[link]
Estrogen supplementation, in anorexia nervosa,
[link]
Ethical issues, in anxiety disorders,
[link]
Ethnocultural factors, in depression,
[link]
Event-related potentials (ERPs)
in schizophrenia mismatch negativity and postonset progression of abnormalities,
[link]
Evidence-based mental health services,
[link] organizational context findings,
[link] research gaps categorization of practices,
[link] diagnostic classification,
[link] implementation and dissemination,
[link] lab-to-clinic translatability,
[link] summary and recommendations,
[link] lack of family-driven practices,
[link]
Evidence-based policies,
[link]
Evidence-based practices substance abuse treatment,
[link]
Evidence-Based Practices Project (EBPP) for Suicide Prevention,
[link]
Executive inhibitory circuitry defects, in substance use disorders,
[link]
Exercise, weight-bearing, in anorexia nervosa,
[link]
Exposure and ritual prevention (EX/RP), for obsessive-compulsive disorder,
[link]t,
[link],
[link]
Expressed emotions, reduction, family therapy for,
[link]
Extracurricular activities, for positive youth development,
[link]
Extrapyramidal side effects, in schizophrenia,
[link]
Familial aggregation, in schizophrenia,
[link]
Family-based interventions in major depressive disorder,
[link]
Family-driven practices, lack of attention to,
[link]
Family history major depressive disorder and,
[link]
Family therapy attachment-based, for major depressive disorder,
[link] functional, state-level implementation,
[link]
(p. 801)
for
substance use disorders,
[link] for
suicide attempters,
[link]
Fat, body, fear of, as criterion for anorexia nervosa,
[link]
Fear of
body fat or weight gain, as criterion for anorexia nervosa,
[link] brain circuitry for, developmental shifts,
[link] stranger, absence of, schizophrenia and,
[link]
Fear structures, in anxiety disorders cognitive-behavioral therapy and,
[link] emotional processing theory and,
[link]
Feeding problems, early, bulimia nervosa and,
[link]
Financing for
evidence-based mental health services,
[link] for
suicide prevention evaluation studies,
[link]
Finding Hope and Help program, suicide prevention,
[link]
Flow state in positive psychology,
[link] in positive youth development,
[link]
Fluid abnormalities, in eating disorders,
[link]t
Fluoxetine for
generalized anxiety disorder,
[link] for
major depressive disorder with substance use disorder,
[link] for
obsessive-compulsive disorder,
[link] for
post-traumatic stress disorder,
[link] for
suicide attempters,
[link]
Flupenthixol, for schizophrenia,
[link]t
Fluvoxamine for
major depressive disorder,
[link] for
obsessive-compulsive disorder,
[link] for
separation anxiety disorder,
[link]
Focus on Families Program,
[link]
Frontal-temporal circuitry, in schizophrenia,
[link]
Frontal white matter volume, developmental changes,
[link]
Functional family therapy, state-level implementation,
[link]
Future expectations, positive, as outcome of positive youth development,
[link]
Gamma-band activity, in schizophrenia,
[link]
Gammahydroxybutyrate (GHB),
[link]
Gang affiliation, and anxiety disorders,
[link]
Gastrointestinal abnormalities, in eating disorders,
[link]t
Gatekeeper training, for suicide prevention,
[link]t,
[link]
Gender differences substance abuse treatment,
[link]
Gene expression, hormones and,
[link]
Generalized anxiety disorder,
[link] treatment,
[link]t,
[link]t
in children and adolescents,
[link] management of partial response and nonresponse to,
[link]
Genes, susceptibility in substance use disorders,
[link]
Genetic counseling, in schizophrenia,
[link]
Genome scans in substance use disorders,
[link]
Glucocorticoids, in stress response,
[link]
Glutamate, in drug addiction,
[link]
Great Ormond Street criteria for eating disorders,
[link]
Great Smoky Mountain Study, comorbidity findings,
[link]
Growth hormone, in major depressive disorder,
[link]
Growth retardation, in anorexia nervosa,
[link]
Guanfacine, for post-traumatic stress disorder,
[link]
Gymnastics, anorexia nervosa and,
[link]
Haloperidol with lithium, for bipolar disorder,
[link]
Happiness, “authentic,” in positive psychology,
[link]
Harm avoidance, and vulnerability to depression,
[link]
Hawaii, reform initiatives on delivery of evidence-based practices,
[link]
Headache, depression and,
[link]
Health insurance public, policy shift to,
[link]
Health weight regulation (HWR) model, for eating disorder prevention,
[link]
Hematopoietic abnormalities, in eating disorders,
[link]t
Heroin use medications for long-term treatment,
[link]
Heschl gyrus, in schizophrenia,
[link]
Heterocyclic antidepressants, for major depressive disorder,
[link]
Homosexuality, suicidal behavior and,
[link]
Hopelessness, suicidal behavior and,
[link]
Hormone replacement therapy, in anorexia nervosa,
[link]
HPA (hypothalamic-pituitary-adrenal) axis.
See[link]
HPG (hypothalamic-pituitary-gonadal) axis,
[link]
Human potential, in positive psychology movement,
[link]
Hypokalemia, in bulimia nervosa,
[link]
Hypomania, in bipolar disorder,
[link]
Hyponatremia, in anorexia nervosa,
[link]
Hypothalamic-pituitary-adrenal (HPA) axis
in schizotypal personality disorder,
[link]
Hypothalamic-pituitary-gonadal (HPG) axis,
[link]
Iceland, depression prevention program,
[link]
Immunology, in anxiety disorders,
[link]
Impulse control disorder, in drug addiction,
[link],
[link]f
Indicated prevention programs,
[link] major depressive disorder,
[link]
Infant, depression in, stress and,
[link]
Infertility, in anorexia nervosa,
[link]
Information processing, in schizophrenia, event-related indices,
[link],
[link]t
Innovation, diffusion of, organizational context findings,
[link]
Inpatient treatment substance use disorders,
[link]
Intelligent quotient, in children of schizophrenic parents,
[link],
[link]f
International Classification of Diseases, Tenth Revision (ICD-10),
[link]
Internet interventions/surveys reducing stigma of mental illness,
[link]
Interpersonal relationships alcohol use disorders and,
[link]
Interpersonal skills, as outcome of positive youth development,
[link]
Interpersonal student conflict, school professional findings,
[link],
[link]t
Interpersonal therapy for
bipolar disorder, with social rhythm therapy,
[link] for
major depressive disorder
Interpretative threat bias, in anxiety disorders,
[link]
Interventions in adolescence.
See also specific types, e.g.,
[link]
Interview motivational, in substance use disorders,
[link] psychiatric, in schizophrenia,
[link]
Ipecac abuse, in bulimia nervosa,
[link]
Juvenile justice system, substance abuse services,
[link],
[link]
Kentucky anti-marijuana campaign,
[link] reform initiatives on delivery of evidence-based practices,
[link]
Lab-to-clinic translatability, of evidence-based mental health services,
[link]
Lamotrigine, for bipolar disorder,
[link]
Language delay, in schizophrenia, premorbid abnormalities,
[link],
[link]f
Leadership, organizational,
[link]
Learning theories, in anxiety disorders,
[link]
Legal issues, in suicidal behavior,
[link]
Life Goals Program, for bipolar disorder,
[link]
Life satisfaction, in positive youth development,
[link]
Life Skills Training Program,
[link]
Life stress, early hypothalamic-pituitary-adrenal axis hyperactivity,
[link]
Linkage disequilibrium studies, in schizophrenia,
[link]
Linkage studies in substance use disorders,
[link]
LSD (lysergic acid diethylamide),
[link]
MacArthur Foundation Youth Mental Health Network,
[link]
Magnetic resonance imaging brain volumetric, in schizophrenia,
[link] functional, in anxiety disorders,
[link] morphometric, in anxiety disorders,
[link]
Magnetic resonance spectroscopy, in anxiety disorders,
[link]
Magnetoencephalography, in schizophrenia,
[link]
Major depressive disorder.
See[link]
Malnutrition maternal, anorexia nervosa and,
[link]
Mania.
See also[link] comorbidity attention-deficit/hyperactivity disorder,
[link]
Marital behavioral therapy, for major depressive disorder,
[link]
Mass media drug abuse prevention campaigns,
[link] misinformation about mental illness,
[link] for
reducing stigma of mental illness,
[link]
Maternal-infant therapy, for depression,
[link]
Maternal malnutrition, anorexia nervosa and,
[link]
Maudsley method, in anorexia nervosa,
[link]
Meaning, pursuit of, in positive psychology,
[link]
Medicaid behavioral managed care,
[link] expansion of mental health services,
[link]
Medical disorders, depression and,
[link]
Melancholic features, depression with,
[link]
Menarche, early, bulimia nervosa and,
[link]
Mental health disorders,
[link].
See also specific disorders, e.g.,[link] call to action,
[link] drug treatment of depression,
[link] early detection and treatment as prevention strategy,
[link] diagnostic classification, research gaps,
[link] failure to treat, consequences,
[link] in primary care setting.
See[link]
Mental Health Parity Act,
[link]
Mental health professionals physician collaboration with,
[link]
Mental health services in primary care settings.
See under[link]
Methodological Epidemiologic Catchment Area Study,
[link],
[link]t
Mexican Americans access to mental health services,
[link]
Michigan, reform initiatives on delivery of evidence-based practices,
[link]
Minnesota Twelve-Step model, for substance use disorders,
[link],
[link]
Minor consent for services,
[link]
Molecular genetic studies, in schizophrenia,
[link]
Molindone, for schizophrenia,
[link]t
Monitoring the Future (MTF) study,
[link]
Monoamine oxidase inhibitors, for major depressive disorder,
[link]
Moral competence, as outcome of positive youth development,
[link]
Motivational interview, in substance use disorders,
[link]
Multidimensional Anxiety Scale for Children (MASC),
[link]
Multidimensional family therapy, for substance use disorders,
[link]
Multisystemic therapy, for substance use disorders,
[link]
Naltrexone for
alcohol use disorders,
[link]
National Alliance for Mental Illness,
[link]
National Annenberg Risk Survey of Youth (NARSY),
[link],
[link]t
National Comorbidity Survey,
[link]
National Household Survey on Drug Use and Health (NHSDUH),
[link]
National Institute of Mental Health Center for Prevention Research,
[link]
National Registry of Effective Practices (NREP),
[link]
National Youth Anti-Drug Media Campaign,
[link]
Native Americans suicide prevention programs,
[link]
Nefazodone, for major depressive disorder
Negative cognitions, and vulnerability to depression,
[link]
Negative self-talk, reduction, for anxiety disorders,
[link]
Negative symptoms, in schizophrenia,
[link]
Networks of care, interorganizational, for substance abuse treatment,
[link]
Neuregulin 1, as schizophrenia susceptibility gene,
[link]
Neuroanatomic studies, in schizophrenia,
[link]
Neurobehavioral deficits, in schizophrenia,
[link]
Neurobiology substance use disorders,
[link]
Neurochemistry, anxiety disorders,
[link]
Neurogenesis, postnatal,
[link]
Neuroimaging in substance use disorders,
[link]
Neuropsychological deficits, in children of schizophrenic parents,
[link]
Neuroticism as
risk factor for psychopathology,
[link] and
vulnerability to depression,
[link]
Neurotransmitter systems.
See also specific types, e.g.,[link]
New York, reform initiatives on delivery of evidence-based practices,
[link]
Nicotine receptors, smoking and,
[link]
Nicotine-replacement therapy (NRT),
[link]
Novelty, amygdala response to,
[link]
Np (processing negativity), in schizophrenia,
[link]t,
[link]
Nurse practitioner, school-based,
[link]t
Obesity professionally administered weight loss programs for,
[link]
Obsessive-compulsive disorder in children and adolescents,
[link] treatment,
[link]t,
[link]t
in children and adolescents,
[link] management of partial response and nonresponse to,
[link]
Obstetrics-gynecology, and early detection and screening of anxiety disorders,
[link]
Ohio, reform initiatives on delivery of evidence-based practices,
[link]
Olanzapine for
post-traumatic stress disorder,
[link]
Ondansetron, for bulimia nervosa,
[link]
Opioid abuse medications for long-term treatment,
[link]
Opioid system, alcohol abuse and,
[link]
Oppositional disorder, plus anxiety,
[link]
Organizational context, impact on service delivery,
[link]
Overanxious disorder.
See[link]
Overweight children and adolescents, professionally administered weight loss programs for,
[link]
Pacific Islanders, suicide rate,
[link]
Panic attacks, neuroticism and,
[link]
Panic disorder in children and adolescents,
[link] treatment,
[link]t,
[link]t
in children and adolescents,
[link] management of partial response and nonresponse to,
[link]
Parent(s) physician likelihood of discussing adolescent mental health problems with,
[link],
[link]t
substance use by, and offspring substance use,
[link] suicidal, and offspring suicide,
[link]
Parent-child interaction treatment (PCIT), state-level implementation,
[link]
Parenting dimension in alcohol use disorders,
[link]
Paroxetine for
major depressive disorder
Partnership for a Drug-Free America,
[link]
Patterson's developmental theory of substance abuse,
[link]
P50–early sensory gating endophenotype, in schizophrenia,
[link],
[link]
Pemoline, for ADHD plus substance use disorder,
[link]
Perfectionism, bulimia nervosa and,
[link]
Performance-limited social anxiety,
[link]
Perinatal events, anorexia nervosa and,
[link]
Personal Assessment and Crisis Evaluation (PACE) clinic,
[link]
Personal Growth Class (PGC),
[link]
Personality in children of schizophrenic parents,
[link] major depressive disorder and,
[link]
Personality disorder(s) borderline, plus suicidal behavior, dialectical behavioral therapy for,
[link] cluster C, plus anorexia nervosa,
[link]
Pessimistic attributional style and
vulnerability to depression,
[link]
Pharmacotherapy,
[link] for
anxiety disorders with cognitive-behavioral therapy,
[link]
(p. 808)
for
major depressive disorder.
See also[link] for
substance use disorders,
[link] for
suicide attempters,
[link]
Phobia in children and adolescents,
[link] treatment,
[link]t,
[link]t
in children and adolescents,
[link] management of partial response and nonresponse to,
[link]
Physical abuse, suicidal behavior and,
[link]
Physical activity modifications, in youth,
[link]
Pimozide, for schizophrenia,
[link]t
Pindolol, augmentation effect, in panic disorder,
[link]
Pleasure, pursuit of, in positive psychology,
[link]
Political interventions, for prevention of major depressive disorder,
[link]
Popular culture, influences,
[link]
Population stratification artifact,
[link]
Positive psychology integration with positive youth development field,
[link] as
outcome target for anxiety prevention studies,
[link]
Positive rehabilitation,
[link]
Positive youth development,
[link] [link] for
at-risk and troubled youth,
[link] institutions that enable,
[link] integration with positive psychology movement,
[link] natural history studies,
[link] versus problem-centered approaches,
[link] summary of current knowledge,
[link]
Post-traumatic stress disorder alcohol use disorders and,
[link] in children and adolescents,
[link] treatment,
[link]t,
[link]t
in children and adolescents,
[link] management of partial response and nonresponse to,
[link]
Poverty school mental health services and,
[link]
Prefrontal-striatal circuitry, in schizophrenia,
[link]
Premature birth, anorexia nervosa and,
[link]
President's New Freedom Commission on Mental Health (2003),
[link],
[link]
Prevention early detection and treatment as strategy for,
[link]
Prevention programs,
[link].
See also specific disorders major depressive disorder,
[link]
Primary care setting adolescent mental health problems in,
[link] [link] treatment collaborative relationships,
[link] perceived effectiveness,
[link] physician survey summary and conclusions,
[link]
Problem behavior theory of substance abuse,
[link]
Problem-centered approach to youth development,
[link]
Problem-solving therapy for
major depressive disorder,
[link] for
suicide attempters,
[link]
Promoting Alternative Thinking Strategies program,
[link]t
Propanolol, for post-traumatic stress disorder,
[link]
Prosocial involvement, as outcome of positive youth development,
[link]
Psychiatric interview, in schizophrenia,
[link]
Psychiatry, and early detection and screening of anxiety disorders,
[link]
Psychobehavioral influences, in alcohol use disorders,
[link]
Psychodynamic therapy, brief, for major depressive disorder,
[link]
Psychoeducation.
See also[link] for
reducing stigma of mental illness,
[link]
Psychological characteristics, of positive youth development,
[link]
Psychological debriefing,
[link]
Psychological factors, in smoking,
[link]
Psychologist referral to, primary care physician practices,
[link]
Psychology, positive integration with positive youth development field,
[link]
Psychopharmacotherapy.
See[link]
Psychosocial rehabilitation,
[link]
Psychosocial therapy.
See also specific types, e.g.,[link] lab-to-clinic translatability,
[link] for
major depressive disorder in children and adolescents,
[link] for
substance use disorders,
[link]
Psychotherapy.
See also[link] for
major depressive disorder cognitive-behavioral analysis system of,
[link]
Psychoticism, in schizophrenia,
[link]
Psychotropic drugs,
[link].
See also specific type, e.g.,[link]
Pubertal delay, in anorexia nervosa,
[link]
Pubertal status major depressive disorder and,
[link]
Quantum Opportunities Program,
[link]t
Queensland Early Intervention and Prevention of Anxiety Project,
[link]t
Quetiapine, adjunctive, for bipolar disorder,
[link]
Race/ethnicity and
access to mental health services,
[link]
Rapid Response (RR) emergency department intervention for suicidal adolescents,
[link]t,
[link]
Rating scales, anxiety,
[link]
Readiness to change, organizational,
[link]
Refeeding, in anorexia nervosa,
[link]
Regulatory practices, in evidence-based mental health services,
[link]
Rehabilitation, positive,
[link]
Reimbursement, for substance abuse screening,
[link]
Relaxation exercises, for anxiety disorders,
[link]
Religious participation, for positive youth development,
[link],
[link]t
Research agenda,
[link] evidence-based mental health services,
[link] major depressive disorder,
[link] substance use disorders,
[link]
Resiliency in children of depressed parents,
[link] as
goal of prevention programs,
[link]
Restrained eating, definition,
[link]
Revised Children's Manifest Anxiety Scale (RCMAS),
[link]
(p. 811)
Risperidone augmentation effect, in obsessive-compulsive disorder,
[link]
Route-of-administration principle, addictiveness and,
[link]
Sample size, for prevention studies,
[link]
Schizophrenia,
[link] adolescent-onset, developmental precursors,
[link] brain circuitry in,
[link] implications for adolescence,
[link] comorbid syndromes, adjunctive treatments,
[link] duration of untreated psychosis, outcome and,
[link],
[link] emotion-processing deficits,
[link] endophenotypes molecular genetic studies,
[link] first-episode psychotic relapses after,
[link] treatment of residual symptoms and comorbid syndromes,
[link] magnetoencephalography,
[link] neurobehavioral deficits,
[link] pathophysiology, in adolescence,
[link] positive symptoms, pharmacotherapy,
[link] psychosocial assessment,
[link] residual symptoms, adjunctive treatments,
[link] risk factors and
prevention strategies,
[link]
School refusal.
See also[link] and
detection of anxiety disorders,
[link]
Schools.
See also[link] educational interventions for
reducing stigma of mental illness,
[link] mental health professional survey summary and conclusions,
[link] mental health services,
[link] in low-income versus high-income schools,
[link] treatment programs, suicide attempters,
[link]
Screen for Child Anxiety Related Emotional Disorders,
[link]
Screening in psychiatric care settings,
[link]
Seasonal affective disorder,
[link]
Selective prevention programs,
[link] major depressive disorder,
[link]
Selective serotonin and noradrenaline reuptake inhibitors, for major depressive disorder,
[link]
Selective serotonin reuptake inhibitors for
anxiety disorder, with substance use disorder,
[link] for
major depressive disorder with substance use disorder,
[link] for
obsessive-compulsive disorder,
[link] for
separation anxiety disorder,
[link] for
suicide attempters,
[link]
Self-esteem/social competence (SESC) model, for prevention of eating disorders,
[link]
Seligman program, for prevention of depression,
[link],
[link]t
Separation, depression and,
[link]
Separation anxiety disorder
Septal-hippocampal system, in anxiety disorders,
[link]
Serotonin and noradrenaline reuptake inhibitors, selective, for major depressive disorder,
[link]
Serotonin reuptake inhibitors, selective.
See[link]
Serotonin transporter polymorphism
Sertraline for
generalized anxiety disorder,
[link] for
major depressive disorder for
obsessive-compulsive disorder,
[link] for
post-traumatic stress disorder,
[link]
Service delivery systems mental health organizational context findings,
[link] substance abuse,
[link] limited assessment practices,
[link] limited scope and appropriateness,
[link] system change considerations,
[link]
Services for Teens at Risk (STAR) Center Outreach program,
[link]
Sexual abuse post-traumatic stress disorder and,
[link] victim identification, primary care physician findings,
[link],
[link]t
Sexual assault, depression and,
[link]
Sexual behaviors, high-risk, alcohol-related,
[link]
Sexual orientation, suicidal behavior and,
[link]
Short stature, in anorexia nervosa,
[link]
Sibling influences, in alcohol use disorders,
[link]
Sibutramine, for bulimia nervosa,
[link]
Signal transduction, in drug addiction,
[link]
Skeletal abnormalities, in eating disorders,
[link]t
Skills, Opportunities, and Recognition program,
[link]t
Skin abnormalities, in eating disorders,
[link]t
Social anxiety disorder in children and adolescents,
[link]
Social Anxiety Scale for Children–Revised,
[link]
Social competence, as outcome of positive youth development,
[link]
Social Phobia and Anxiety Inventory for Children,
[link]
Social rhythm therapy, interpersonal therapy with, for bipolar disorder,
[link]
Social skills as
protective factor in suicide,
[link] training for
major depressive disorder,
[link]
Societal factors, in alcohol use disorders,
[link]
Society for Adolescent Medicine, eating disorders treatment guidelines,
[link]
Socioeconomic status school mental health services and,
[link]
Socioenvironmental factors, in smoking,
[link]
Sociotropy, depression and,
[link]
Special-education system, substance abuse identification in,
[link]
Spence Children's Anxiety Scale,
[link]
Sports participation, anorexia nervosa and,
[link]